微电生理(688351.SH)：2025年净利润5115.17万元，同比下降1.76%

Core Viewpoint - Microelectrophysiology (688351.SH) reported a total operating revenue of 465 million yuan for the year 2025, representing a year-on-year growth of 12.43%, while the net profit attributable to the parent company decreased by 1.76% to 51.15 million yuan [1] Financial Performance - The company achieved a net profit of 23.66 million yuan after deducting non-recurring gains and losses, a significant increase from 5.08 million yuan in 2024 [1] International Expansion - The company's overseas revenue grew by over 40% year-on-year, accounting for more than 30% of total revenue, indicating the effective implementation of its internationalization strategy [1] - High-end pressure monitoring radiofrequency ablation catheters have been commercialized in over 20 countries [1] - The cryoablation system received EU certification and is being commercially applied in countries such as Germany, Turkey, and Greece, with positive clinical feedback [1] Brand and Market Development - The company actively participated in major international academic conferences, showcasing its "electric fire ice" comprehensive solution through high-quality live surgeries and seminars, gaining widespread attention and recognition in the industry [1] - Future strategies include continuous product innovation, strengthening brand development, and expanding channel networks to enhance competitiveness in overseas markets [1]